Pharmacology, Toxicology and Pharmaceutical Science
Acute Otitis Media
8%
Asthma
22%
Biological Product
17%
Biosimilar Agent
8%
Breast Cancer
17%
Bronchitis
8%
Broxuridine
60%
C57BL 6 Mouse
17%
Caffeic Acid Phenethyl Ester
17%
Choline Alfoscerate
17%
Chronic Disease
17%
Chronic Obstructive Lung Disease
17%
Cohort Study
36%
Community Pharmacy
17%
Cornea Opacity
12%
Dermatitis
17%
Dexamethasone
17%
Diabetic Macular Edema
17%
Diazepam
17%
Diet Induced Obesity
17%
Disease
28%
Disease Model
17%
Drug
8%
Endothelial Cell Growth Factor
17%
Enzyme-Linked Immunosorbent Assay
10%
Epidemiology
17%
Eye Irritation
60%
Flow Cytometry
42%
Hospital Pharmacy
17%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
17%
Implant
17%
Insulin Analog
8%
Irritant Agent
38%
Leporidae
17%
Life Expectancy
17%
Long Acting Insulin
8%
Malignant Neoplasm
34%
Monoamine
17%
Neurotransmitter
17%
Omeprazole
17%
Open Angle Glaucoma
17%
Prescription Drug
21%
Prevalence
17%
Retrospective Study
17%
Serotonin
17%
Skin Irritation
34%
Statin (Protein)
17%
Sudden Infant Death Syndrome
8%
Toxicological Sciences
17%
Ulcer Perforation
17%
Medicine and Dentistry
Adolescence
8%
Antithrombotic
17%
Asthma
14%
Atrial Fibrillation
17%
Biological Product
8%
Biosimilar
25%
Bone Density
8%
Breast Cancer
17%
Bromodeoxyuridine
13%
Cell Therapy
8%
Cervical Cancer
17%
Cohort Effect
17%
Decision Making
28%
Dexamethasone
17%
Diabetes
12%
Diabetes Mellitus
19%
Diabetic Macular Edema
17%
Disease
11%
Drug
17%
Drug Therapy
26%
Endothelial Cell Growth Factor
17%
Flow Cytometry
8%
Gastroesophageal Reflux
17%
Health Care Cost
100%
Health Care Utilization
17%
Health Outcomes
15%
Intravitreal Implant
17%
Logistic Regression Analysis
20%
Long Acting Insulin
17%
Malignant Neoplasm
62%
Medication Compliance
25%
Meta-Regression
17%
Multiple Chronic Conditions
17%
Multiple Myeloma
17%
Nivolumab
8%
Non Small Cell Lung Cancer
17%
Odds Ratio
10%
Omeprazole
17%
Oropharynx Carcinoma
17%
Patient Experience
17%
Pembrolizumab
8%
Peptic Ulcer Bleeding
8%
Prescription Drug
17%
Prevalence
22%
Rebound
17%
Retrospective Study
17%
Sensitization
22%
Sex Difference
17%
Treatment Duration
14%
Vitamin K Antagonist
17%
Nursing and Health Professions
Adalimumab
8%
Adolescent
8%
Benzodiazepine Derivative
17%
Biosimilar Agent
8%
Broxuridine
25%
Chimeric Antigen Receptor T-Cell Immunotherapy
8%
Comorbidity
5%
Confidence Interval
7%
Cost Effectiveness Analysis
5%
Cross-Sectional Study
8%
Disease
10%
Drug Therapy
24%
Drug Use
8%
Economic Evaluation
7%
Eye Irritation
17%
Flow Cytometry
25%
Gastroesophageal Reflux
17%
Gastrointestinal Agent
8%
Health Care Cost
34%
Health Care Utilization
17%
Health Outcomes
18%
Health Service
18%
Health Status
18%
Incremental Cost-Effectiveness Ratio
8%
Independent Practice Association
8%
Inferential Statistics
12%
Local Lymph Node Assay
25%
Medication Compliance
25%
Mortality Rate
7%
National Health Insurance
34%
Nonsteroid Antiinflammatory Agent
5%
Odds Ratio
7%
Open Angle Glaucoma
17%
Patient with Depression
5%
Practice Guideline
12%
Prevalence
21%
Quality Adjusted Life Year
21%
Quality of Life
20%
Reproducibility
37%
Treatment Duration
12%
Ulcer Perforation
17%
